May 2026 Olympus Corporation entered into an exclusive global distribution agreement with EndoRobotics to add robot-assisted technologies to its EndoTherapy portfolio. The collaboration aimed to expand access to advanced minimally invasive procedures by integrating robotic technologies into Olympus’ procedural solutions portfolio.
May 2026 Cornerstone Robotics received CE Mark MDR approval for its Sentire Endoscopic Surgical System, enabling access to European markets for minimally invasive procedures across general surgery, gynecology, thoracic surgery, and urology. The regulatory milestone supported the company’s global expansion strategy in robotic-assisted laparoscopic surgery.
December 2025 Intuitive Surgical received U.S. FDA clearance for expanded indications of its da Vinci Single Port (SP) surgical system, allowing use in additional laparoscopic procedures including inguinal hernia repair, cholecystectomy, and appendectomy. The approval broadened the application scope of single-port robotic-assisted minimally invasive surgery.
July 2025 Intuitive Surgical received CE Mark approval for its da Vinci 5 Surgical System in Europe, expanding its use across multiple minimally invasive endoscopic procedures, including general laparoscopic, urologic, gynecologic, and thoracic surgeries. The approval supported the company’s continued expansion of advanced robotic-assisted laparoscopy technologies in European markets.